Hollencrest Capital Management’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Hollencrest Capital Management’s Portfolio DMK Stock Details DMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-28	Closed	-$20	–	1155
2023 Q4	$20	Hold	28	–	–	﹤0.01%	1028
2023 Q3	$19	Hold	28	–	–	﹤0.01%	1055
2023 Q2	$67	Sell	28 -1	-3%	-$4	﹤0.01%	1096
2023 Q1	$232	Hold	29	–	–	﹤0.01%	1090
2022 Q4	$339	Buy	+29	New	+$331	﹤0.01%	1076

Other funds holding DMK

CPA

Clear Point Advisors Melville, New York $129M AUM 12.02% 1-Year Est. Return

OPTFSNA

Old Point Trust & Financial Services N A Newport News, Virginia $311M AUM 24.14% 1-Year Est. Return

Hollencrest Capital Management's DMK Position: Q1 2024 in Review

Hollencrest Capital Management sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q1 2024, closing a stake of 28 shares — an estimated $20 sold.

Hollencrest Capital Management first reported a position in DMK in Q4 2022 and held it in 5 quarters. The position peaked at $339 in Q4 2022. 3 funds tracked by Wall St. Rank hold DMK as of Q1 2024.

Hollencrest Capital Management reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q1 2024 after selling out during the quarter.
Hollencrest Capital Management sold 28 DMK Pharmaceuticals Corporation Common Stock shares in Q1 2024, an estimated $20.
Hollencrest Capital Management first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q4 2022 and held it in 5 quarters.
Hollencrest Capital Management's DMK Pharmaceuticals Corporation Common Stock position peaked at $339 in Q4 2022.
3 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q1 2024.

Based on Hollencrest Capital Management's 13F filing for Q1 2024, filed 1 May 2024.